Truist Financial Corp Sells 148 Shares of Mettler-Toledo International, Inc. $MTD

Truist Financial Corp decreased its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 13.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 934 shares of the medical instruments supplier’s stock after selling 148 shares during the quarter. Truist Financial Corp’s holdings in Mettler-Toledo International were worth $1,097,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Greenleaf Trust grew its stake in Mettler-Toledo International by 1.2% in the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier’s stock valued at $1,030,000 after buying an additional 10 shares in the last quarter. Brooklyn Investment Group grew its stake in Mettler-Toledo International by 12.8% in the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier’s stock valued at $104,000 after buying an additional 10 shares in the last quarter. Sequoia Financial Advisors LLC grew its stake in Mettler-Toledo International by 1.8% in the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier’s stock valued at $740,000 after buying an additional 11 shares in the last quarter. Albion Financial Group UT grew its stake in Mettler-Toledo International by 1.5% in the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier’s stock valued at $890,000 after buying an additional 11 shares in the last quarter. Finally, TD Private Client Wealth LLC grew its stake in Mettler-Toledo International by 5.4% in the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier’s stock valued at $253,000 after buying an additional 11 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

MTD opened at $1,274.39 on Monday. Mettler-Toledo International, Inc. has a one year low of $946.69 and a one year high of $1,486.76. The firm has a market capitalization of $26.25 billion, a P/E ratio of 32.27, a price-to-earnings-growth ratio of 3.82 and a beta of 1.37. The company has a fifty day moving average price of $1,278.97 and a 200-day moving average price of $1,190.01.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same period in the previous year, the firm posted $9.65 EPS. The firm’s revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on MTD shares. Evercore ISI lifted their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. JPMorgan Chase & Co. lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the company a “neutral” rating in a research note on Thursday. Robert W. Baird lifted their price objective on shares of Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a “neutral” rating in a research note on Monday, August 4th. Citigroup boosted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Thursday, August 21st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and a consensus price target of $1,336.50.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. The trade was a 5.56% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the sale, the insider directly owned 94 shares of the company’s stock, valued at $123,012.16. This represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,827 shares of company stock valued at $2,371,208. Insiders own 0.77% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.